Literature DB >> 14560365

Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus.

Joerg Theisen1, Jeffrey H Peters, Hubert J Stein.   

Abstract

The aim of this article is to review the current experimental knowledge of mutagenesis in Barrett's esophagus (BE) with special emphasis on the effect of bile salts and acid. Human evidence of direct mutagenicity is rare. Only the correlation of increased quantities and a change in the quality of bile salts with the complications of duodenogastric reflux such as BE and esophageal adenocarcinoma as an indirect marker of mutagenicity has been shown in several studies. Further evidence comes from p53 studies demonstrating an increased number of mutated p53 genes in patients with BE, esophageal adenocarcinoma, or both. Most animal and cellular experiments are carried out in a neutral pH environment, not reflecting the true nature of a reflux episode. The few studies using moderate low acid reflux conditions in combination with bile salts demonstrated a combined effect on mutagenicity. Our current knowledge of bile salt mutagenicity is predominantly based on experiments with hepatocytes and colon cancer cell lines. Future studies must be aimed at esophageal cell lines, cultured Barrett's tissue, and esophageal adenocarcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560365     DOI: 10.1007/s00268-003-7055-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine.

Authors:  M Pera; A Cardesa; J A Bombi; H Ernst; C Pera; U Mohr
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

2.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model.

Authors:  D Armstrong; E R Rytina; G M Murphy; R H Dowling
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

4.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

5.  Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.

Authors:  J R Spivey; S F Bronk; G J Gores
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Role of the components of the gastroduodenal contents in experimental acid esophagitis.

Authors:  K D Lillemoe; L F Johnson; J W Harmon
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

Review 7.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

8.  Alkaline esophagitis: a comparison of the ability of components of gastroduodenal contents to injure the rabbit esophagus.

Authors:  K D Lillemoe; L F Johnson; J W Harmon
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

9.  Bile acid concentrations in the refluxate of patients with reflux oesophagitis.

Authors:  D C Gotley; A P Morgan; M J Cooper
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

10.  Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria.

Authors:  S Krähenbühl; C Talos; S Fischer; J Reichen
Journal:  Hepatology       Date:  1994-02       Impact factor: 17.425

View more
  9 in total

Review 1.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects.

Authors:  Ali Siddiqui; Sheila Rodriguez-Stanley; Sattar Zubaidi; Philip B Miner
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  Effects of refluxate pH values on duodenogastroesophageal reflux-induced esophageal adenocarcinoma.

Authors:  Peng Cheng; Jian-Sheng Li; Jun Gong; Lian-Feng Zhang; Rong-Zhong Chen
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

4.  Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus.

Authors:  Kathleen O'Connell; Vic Velanovich
Journal:  Surg Endosc       Date:  2010-07-30       Impact factor: 4.584

Review 5.  Gender difference in gastro-esophageal reflux diseases.

Authors:  Kiyotaka Asanuma; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

6.  Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus.

Authors:  Peng Cheng; Jian-Sheng Li; Lian-Feng Zhang; Yong-Zhong Chen; Jun Gong
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 7.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Should peri-gastrectomy gastric acidity be our focus among gastric cancer patients?

Authors:  Lei Huang; A-Man Xu; Tuan-Jie Li; Wen-Xiu Han; Jing Xu
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Anouk van de Winkel; Vivianda Menke; Astrid Capello; Leon M G Moons; Raymond G J Pot; Herman van Dekken; Peter D Siersema; Johannes G Kusters; Luc J W van der Laan; Ernst J Kuipers
Journal:  BMC Gastroenterol       Date:  2011-10-06       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.